Literature DB >> 8082789

Predominant role of the substituents on the hydroxyl groups of 3-hydroxy fatty acids of non-reducing glucosamine in lipid A for the endotoxic and antagonistic activity.

K Tanamoto1.   

Abstract

The synthetic disaccharide precursor of lipid A (406: identical to lipid IVA) was found to reduce its endotoxic activity in mice by an order of 10(5) or more, by replacing the hydroxyl groups with succinyl or acetyl residues. Both the succinylated and acetylated 406 were also found to antagonize the endotoxic mitogenicity on murine splenocytes. Previous studies demonstrated that the succinylated or acetylated synthetic complete lipid A preparations retained the whole endotoxic activity [1994, Infect. Immunol. 62, 1705]. The drastic contrast in all of these results suggests the importance of the substituents on the hydroxyl groups of 3-hydroxy fatty acids of non-reducing glucosamine of lipid A for the activity and for transformation to the antagonistic structure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082789     DOI: 10.1016/0014-5793(94)00857-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Biological properties of lipid A isolated from Flavobacterium meningosepticum.

Authors:  K Tanamoto; H Kato; Y Haishima; S Azumi
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Chemical structure of lipid A isolated from Flavobacterium meningosepticum lipopolysaccharide.

Authors:  H Kato; Y Haishima; T Iida; A Tanaka; K Tanamoto
Journal:  J Bacteriol       Date:  1998-08       Impact factor: 3.490

3.  Dissociation of endotoxic activities in a chemically synthesized lipid A precursor after acetylation.

Authors:  K Tanamoto
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

4.  Induction of lethal shock and tolerance by Porphyromonas gingivalis lipopolysaccharide in D-galactosamine-sensitized C3H/HeJ mice.

Authors:  K Tanamoto
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.